Topical Collection on Evidence-Based Medicine, Clinical Trials and Their Interpretations

ISSN: 1523-3804 (Print) 1534-6242 (Online)

In this topical collection (44 articles)

Page of 3

  1. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)

    Herbal Approach for Management of Atherosclerosis: a Review

    Sanjiv Singh Article:12

  2. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)

    Health Factors Associated with Cardiovascular Wellness

    Mahmoud Al Rifai, Miguel Cainzos-Achirica… Article:10

  3. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)

    Mitral Annular Calcification: Association with Atherosclerosis and Clinical Implications

    Luiz Rafael P. Cavalcanti, Michel Pompeu B. O. Sá… Article:9

  4. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)

    Profiling the Acute Effects of Modified Risk Products: Evidence from the SUR-VAPES (Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking) Cluster Study

    Giacomo Frati, Roberto Carnevale, Cristina Nocella… Article:8

  5. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)

    High-Intensity Interval Training in Patients with Type 2 Diabetes Mellitus: a Systematic Review

    Djeniffer Elias da Silva, Antônio José Grande… Article:8

  6. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)

    Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning–Based Tissue Characterization

    Narendra N. Khanna, Ankush D. Jamthikar, Deep Gupta… Article:7

  7. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)

    Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents

    Giuseppe Biondi-Zoccai, Cristian M. Garmendia… Article:4

  8. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)

    Calcific Aortic Valve Stenosis and Atherosclerotic Calcification

    Michel Pompeu Barros de Oliveira Sá… Article:2

  9. No Access

    Review

    Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease

    Rafal Wolny, Jolien Geers, Kajetan Grodecki… Pages 1-11

  10. No Access

    Review

    Cardiovascular Health and Disease in the Pakistani American Population

    Murrium I. Sadaf, Usman Ali Akbar, Khurram Nasir… Pages 1-11

  11. Review

    Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease

    Omer Akyol, Chao-Yuh Yang, Darren G. Woodside… Pages 1-13
    Download PDF (1328KB) View Article

  12. Review

    Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

    John J. P. Kastelein, Andrew Hsieh, Mary R. Dicklin… Pages 35-44
    Download PDF (939KB) View Article

  13. No Access

    Evidence‐Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)

    Coronary Artery Calcium for Risk Assessment in Young Adults

    Ayman Haq, Michael D. Miedema Pages 337-342

  14. No Access

    Evidence‐Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)

    Moving the Paradigm Forward for Prediction and Risk-Based Primary Prevention of Heart Failure in Special Populations

    Ian K. Everitt, Katherine V. Trinh, Daniel L. Underberg… Pages 343-356

  15. Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)

    Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention

    Aarti Thakkar, Tigist Hailu, Roger S. Blumenthal… Pages 493-507
    Download PDF (1108KB) View Article

  16. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)

    Cardiovascular Prevention Among Young Adults with Congenital Heart Disease

    Matthew R. Lippmann, Ami B. Bhatt Pages 509-514

  17. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)

    Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease

    Nicholas W. S. Chew, Cheng Han Ng, Mark Dhinesh Muthiah… Pages 515-532

  18. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)

    Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management

    Mohamad B. Taha, Tamer Yahya, Priyanka Satish… Pages 643-654

  19. No Access

    Evidence-Based Medicine, Clinical Trials and Their Interpretations​ (K. Nasir, Section Editor)

    Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes

    Kunal K. Jha, Rishav Adhikari, Erfan Tasdighi… Pages 925-937

  20. Evidence-Based Medicine, Clinical Trials and Their Interpretations​ (K. Nasir, Section Editor)

    A Contemporary Review of Epidemiology, Risk Factors, Etiology, and Outcomes of Premature Stroke

    Thomas B. H. Potter, Jonika Tannous, Farhaan S. Vahidy Pages 939-948
    Download PDF (1020KB) View Article
Page of 3